Exploring the Challenges of Designing and Executing First-in-Human Oncology Trials, Upcoming Webinar Hosted by Xtalks
Thursday, April 10, 2025
In this free webinar, learn about the essential considerations for designing and executing first-in-human (FIH) oncology trials. The featured speakers will share best practices for preparing a robust investigational new drug (IND) package to streamline regulatory approval. The speakers will also discuss strategies for effective dose escalation planning and patient safety monitoring. Attendees will gain insight into practical approaches to site initiation, patient recruitment and cohort management as well as overcoming operational and regulatory challenges in early-phase oncology trials.
TORONTO, April 2, 2025 /PRNewswire-PRWeb/ -- First-in-human (FIH) oncology trials serve as a pivotal transition from preclinical research to patient care, marking the first step in validating the safety and biological activity of a novel therapeutic in humans. These early-phase studies generate essential data on dosing, pharmacokinetics and preliminary efficacy signals, setting the stage for subsequent clinical development.
FIH oncology trials require careful preparation and strategic implementation from study design and investigational new drug (IND) submission to site startup, patient recruitment and cohort management. To ensure success, sponsors must navigate a host of challenges to ensure safety, timeliness and scientific validity.
This webinar will highlight key considerations and best practices for designing and executing FIH oncology trials, offering practical solutions to help sponsors navigate the regulatory, operational and clinical hurdles inherent to these studies. The key topics will include:
-- Preparing a robust IND package
-- Developing a clear plan for dose escalation
-- Streamlining site initiation and patient recruitment
-- Managing cohorts and safety review committees
Register for this webinar to explore best practices such as regulatory preparation, site initiation, cohort management and safety monitoring for designing and executing first-in-human oncology trials.
Join experts from Ergomed Clinical Research, Bin Pan, PhD, Executive Director of Operational Strategy; and Juliet Moritz, Senior Vice President of Strategic Solutions & Patient Centricity, for the live webinar on Thursday, April 24, 2025, at 10am EDT (4pm CEST/EU-Central).
For more information or to register for this event, visit Exploring the Challenges of Designing and Executing First-in-Human Oncology Trials.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com, https://xtalks.com
View original content to download multimedia:https://www.prweb.com/releases/exploring-the-challenges-of-designing-and-executing-first-in-human-oncology-trials-upcoming-webinar-hosted-by-xtalks-302418060.html
SOURCE Xtalks
|
|
|
|
|
 |
Asetek - Mandatory Notification of Trade | Jan 22, 2026
|
|
Tomorrowland Brings the Magic to Shanghai for a Spectacular First Indoor Edition in China | Jan 22, 2026
|
|
BC.GAME to Host "Stay Untamed" Night During Abu Dhabi's Packed Web3 Summit Week | Jan 22, 2026
|
|
Rent Manager Earned Best Real Estate Software Product Award and Multiple Review Badges from G2 Platform | Jan 22, 2026
|
|
Auburn University's Applied Research Institute Expands Advanced Manufacturing Capabilities with CF3D Enterprise Cell | Jan 22, 2026
|
|
AMPERA ANNOUNCES LOCATION FOR GLOBAL HEADQUARTERS | Jan 22, 2026
|
|
Gemmy Alerts Customers: Fake Websites Target Holiday Decorators | Jan 22, 2026
|
|
California Divorce Mediation Center Unveils Modern Website Redesign | Jan 22, 2026
|
|
Culture and tourism sectors thrive in Xiamen | Jan 22, 2026
|
|
AMPLIFY Named Finalist in Three Categories at the 2026 Golden Gavel Awards | Jan 22, 2026
|
|
|
